Cyclacel Pharmaceuticals
As of the edition of 20 October 2026, Cyclacel Pharmaceuticals runs 5 drugs; it is on route A at 10 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Went quiet | 1 |
| Stopped | 4 |
| Total | 5 |
Where it needs a new molecule
Route A at 10 targets, route B at 0 targets.
All 10 rows on route A or B
In the product10 company-target rows on route A or B; 7 are not shown here, and no score is.
See all 10 targets where Cyclacel Pharmaceuticals needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Cancer: 13 trials led
- Blood and lymph: 11 trials led
- Immune system: 5 trials led